AJ-VACCINES
På trods af en igangværende indsats for at udrydde polio, har der været en stigning af registrerede poliotilfælde fra 2018 til 2019. Fremadrettet vil AJ Vaccines ’ antigen reducerende teknologi give mulighed for at udvide udbuddet af poliovaccine, med potentiale for at levere op til 100 millioner doser i femårsperioden 2020-2024, hvilket vil dække den uopfyldte globale efterspørgsel på inaktiverede poliovacciner.
Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20200421005974/da/
En milepælspræstation
Udviklingen af den første dosis reducerede enkelt-komponent inaktiverede poliovaccine er en milepæl for den betydelige investering og innovation, der er foretaget i den danske vaccineproduktion. ”WHO's prækvalifikation er en anerkendelse af vores fortsatte investeringer, som gør det muligt for AJ Vaccines at imødekomme den stigende efterspørgsel på effektive poliovacciner, og vi åbner hermed et nyt kapitel i virksomhedens fortsatte rejse mod at bistå den danske befolkning og et stigende antal mennesker globalt” , siger Mr. Abdulaziz Hamad Aljomaih, hovedinvestor i AJ Vaccines.
En hyldest til dedikerede medarbejdere
Opnåelsen af WHO-prækvalifikationen er en hyldest til medarbejderne for deres engagement og deres bidrag, som har involveret en omfattende gennemgang af produktionsprocesser og kvalitetskontrolprocedurer, uafhængig laboratorietestning, vurdering af filer samt en inspektion af produktionsfaciliteter, der er udført i fællesskab mellem WHO og Lægemiddelstyrelsen i 2019. ”Prækvalifikationen er en anerkendelse af vores engagerede medarbejderes kompetencer og ligger i forlængelse af vores virksomheds vision, der stræber efter en verden fri for alvorlige sygdomme på tværs af generationer” , siger dr. Tabassum Khan, formand for AJ Vaccines.
Betydelige investeringer
Picovax®-udviklingsprojektet er støttet af Bill & Melinda Gates Foundation. ”Siden vores overtagelse af AJ Vaccines i 2017 har vi investeret markant i den strategiske udvidelse af vores produktionsfaciliteter og rekrutteret 200 nye medarbejdere for at sikre AJ Vaccines’ position som en betydelig aktør på vaccinemarkedet, der bidrager til det vigtige strategiske globale mål om at udrydde polio” , siger Jesper Helmuth Larsen, administrerende direktør i AJ Vaccines.
Den nye vaccine vil spille en afgørende rolle for The Global Polio Eradication Initiative (GPEI)
Den nye inaktiverede poliovaccine (IPV) er indikeret til aktiv immunisering mod poliomyelitis ved primær vaccination hos spædbørn fra seks uger og til revaccination af spædbørn, børn og unge. En antigen reduceret IPV giver beskyttelse, der kan sammenlignes med den, der opnås ved andre inaktiverede poliovacciner, der i øjeblikket er tilgængelige. ”Den antigen reducerende teknologi sikrer en tiltrængt forøgelse i udbuddet og vil bidrage til at imødekomme det stigende behov for inaktiveret poliovacciner, der støtter The Global Polio Eradication Initiative” , afslutter Jérôme Cabannes, COO AJ Vaccines.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20200421005974/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Prodalim Expands SOLOS Capabilities with New Dealcoholization Site in Spain19.1.2026 08:33:00 CET | Press release
Prodalim, a global leader in juice and specialty ingredients solutions, announced today the expansion of its SOLOS division with the opening of a dedicated dealcoholization and aroma recovery site in Valencia, Spain. The new facility is fully operational and strengthens Prodalim’s ability to support the rapidly growing no- and low-alcohol (NoLo) beverage market across Europe. During the coming months, an additional SOLOS site in California is planned to be inaugurated, further expanding overall capacity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260118626123/en/ Inauguration of the SOLOS Valencia Site for Advanced NoLo Solutions The global NoLo category continues to expand, driven by consumer demand for mindful drinking and healthier lifestyle choices. Industry forecasts estimate the NoLo global market at approximately USD 25 billion in 2025, with expected annual growth of 8–10% as the category expands across beers, win
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer19.1.2026 08:30:00 CET | Press release
Based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s ENHERTU in combination with pertuzumab significantly improved progression-free survival versus current first-line standard of care in HER2 positive metastatic breast cancer The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line treatment of adult patients with unresectable or metastatic HER2 positive breast cancer. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use (CHMP). The application is based on data from the DESTINY
Syngenta to Address Global Agricultural Challenges at WEF, Championing AI to Empower Farmers and Create Open Technology Access19.1.2026 08:00:00 CET | Press release
AI and digital tools are unlocking unprecedented opportunities to strengthen farms and secure food security. New IPSOS study reveals technology adoption gap, underscoring urgent need for equitable technology access. Syngenta champions "Agricultural Intelligence" at World Economic Forum, showcasing Cropwise AI solutions that put cutting-edge tools in the hands of all farmers, especially smallholders. As farmers globally grapple with unprecedented economic, geopolitical, and environmental pressures; the agricultural sector faces a continued contraction. An alarming decrease in active farms worldwide and rising financial distress underscore the urgent need for innovation and technology to ensure a resilient food system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260118646017/en/ Jeff Rowe, Syngenta Group CEO "Farmers today are navigating one of the most complex periods in modern agriculture, facing pressures that demand urg
KPMG Enters Strategic Relationship With Uniphore to Build AI Agents Powered by Industry-Specific Small Language Models19.1.2026 07:00:00 CET | Press release
Collaboration uses KPMG’s knowledge in small language models to accelerate delivery of business outcomes to clients across banking, insurance, energy and healthcare Uniphore, the Business AI company, today announced a strategic relationship with KPMG LLP to operationalize AI agents across internal and client-facing workflows, supporting the firm’s continued effort to move from experimental AI pilots to production-grade deployment. As part of the collaboration, KPMG will work with Uniphore to build AI agents using Uniphore’s Business AI Cloud as a platform for agentic AI and fine-tuned small language models (SLMs), supporting clients across regulated industries including banking, insurance, energy and healthcare. Built on a sovereign, composable, and secure architecture, the platform integrates with KPMG’s existing enterprise systems and data environments, meeting governance and compliance requirements essential to regulated industries. This initiative reflects KPMG’s broader effort to
International Chamber of Commerce, Carbon Measures Announce First Group of Global Experts for Carbon Accounting Panel19.1.2026 06:00:00 CET | Press release
Panelists include senior global leaders from business, academia, and civil society. The International Chamber of Commerce (ICC) and Carbon Measures today announced the first cohort of experts selected to serve on the Technical Expert Panel on Carbon Accounting, which will define the principles, scope and real-world applications of a carbon emissions accounting system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260118104674/en/ The panelists are distinguished leaders and experts across industry, science, civil society, and academia – representing diverse disciplines, geographies, and professional backgrounds. The panel will apply their experience across sustainability, technology, public policy, and industrial and financial systems to establish a timely, accurate and verifiable ledger-based carbon emissions accounting system. This system will track product-level emissions across the value chain and support real-world deci
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum